MedTrace Logo

Repeated Amiodarone Dosing In Cardiac surgicaL Procedures

NCT05004077 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2023-11-18

Study results available
· View outcomes & findings →

Summary

This study is a single-center, prospective, randomized, open-label trial of subjects who develop atrial fibrillation after non-emergent cardiac surgery at the University of Kentucky Chandler Medical Center (UKCMC). Patients will be randomized to receive either a conventional amiodarone dosing regimen (CDR) or a repeated amiodarone bolus dosing regimen (RBDR).

Conditions

Interventions

DRUG

AMIODARONE

Assess the effectiveness of different dosing strategies of amiodarone.

Sponsors & Collaborators

  • Kevin W Hatton, MD, PhD

    lead OTHER

Principal Investigators

  • Kevin Hatton, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-02
Primary Completion
2022-10-10
Completion
2022-10-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05004077 on ClinicalTrials.gov